RA

Rama Avinash Sonalkar

Active Director Director DIN 10576154
DIN 10576154 First appointment Apr 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rama Avinash Sonalkar

Data last updated:

Rama Avinash Sonalkar is a Director at Sweson Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10576154
Primary Designation Director
Industry Paper
First Appointment 02 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Apr 20242024Active

Board colleagues of Rama Avinash Sonalkar

Directorship timeline

Open interactive timeline →
Sweson Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rama Avinash Sonalkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rama Avinash Sonalkar

Rama Avinash Sonalkar currently holds 1 directorship: Sweson Pharmaceuticals Private Limited (Director, since 02 Apr 2024).

Rama Avinash Sonalkar was first appointed on 02 Apr 2024 as Director at Sweson Pharmaceuticals Private Limited.

The current boards of Rama Avinash Sonalkar's companies include Avinash Ramchandra Sonalkar (Sweson Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available